Larger numbers of
senescent cells in a tissue make it more vulnerable to the spread of cancer, contribute to inflammation, and skew the local activity of the immune system.
Not exact matches
Senescence is associated with normal aging, and
senescent cells accumulate
in aged
tissues, which impair the normal functions of the
tissue and contribute to age - related diseases.
This series addresses the contribution of cellular senescence to cardiovascular, neurodegenerative, and arthritic disorders as well as the
senescent phenotypes
in various
tissues and
cell types.
A recent study, led by an international team of researchers confirms that targeted removal of
senescent cells (SnCs), accumulated
in many vertebrate
tissues as we age, contribute significantly
in delaying the onset of age - related pathologies.
Senescent cells have removed themselves from the cycle of replication
in reaction to
cell and
tissue damage, or a local
tissue environment that seems likely to result
in cancer.
Moreover, there are yet other
cell types — such as visceral adipose
tissue macrophages and cytotoxic CD8 + T -
cells —
in which the age - related supernumerary accumulation of dysfunctional and apoptosis - resistant
cells appears to play a highly deleterious role on
tissue function, but where the
cells are not «
senescent»
cells in the classical sense of p16Ink4a expression and the senescence - associated secretory profile observed
in senescent fibroblasts.
On the other hand, there are many other
tissues — notably, the kidney and articular cartilage — where p16Ink4a - expressing
senescent cells appear to be a contributing factor to human and murine degenerative aging, but which were not evaluated
in treated or control mice
in this study, and it would be of interest to see the effects of ablation of p16Ink4a - positive
senescent cells.
But then why do
senescent cells accumulate
in our
tissues with age?
With their deep expertise
in the biology of
senescent cells, the Campisi lab will be focused on fundamental research into questions like how
senescent cells vary
in their susceptibility and resistance to immune clearance (depending on factors like their
tissues of residence or the pathway that led them into senescence); the targets and mechanisms used by NK
cells to clear
senescent cells; and why subsets of
senescent cells might persist when their similarly - situated neighbors are cleared out (and what might allow us to overcome that resistance).
After initial testing demonstrated that their senoablative constructs could eliminate up to 80 % of
senescent cells in cell culture, the Oisín team tested them out
in living mice, showing that it can purge
senescent cells from multiple
tissues in middle - aged animals.
To impute aging phenotypes directly to p16Ink4a - expressing
senescent cells, van Deursen and colleagues with expertise
in the aging and senescence of the relevant
tissues developed and tested the effects of a pharmacologically - inducible system for the ablation of p16Ink4a - expressing
cells.
Rather, the defective checkpoint system was left to proceed, and one of its downstream consequences, which was still under normal regulation — and one known to be directly induced by the normal degenerative aging process — was reversed at the structural level, by clearing out the p16Ink4a - positive
senescent cells that had accumulated to an abnormal degree
in their
tissues.
In addition to halting growth,
senescent cells secrete abnormally large amounts of proteins that inflame the immune system and degrade the normal supporting
tissue architecture.
Senescent cells lose their normal function
in the
tissue, cease dividing, and begin secreting a deadly mix of inflammatory and
tissue - degrading factors collectively known as the senescence - associated secretory phenotype (SASP) that damages and deranges local
tissues.
As the investigators note, the rapid age - related arterial stiffening and cardiac arrhythmias that appear to be at cause for the majority of deaths
in BubR1H / H mice were not attenuated by ablating p16Ink4a - expressing
senescent cells — but these
tissues had little burden of such
cells, so this finding reinforces the conclusion that the multiple aging phenotypes arrested
in these mice when
senescent cells were ablated is attributable specifically to the removal of their baleful influence on local
tissues.
Thus, these animals exhibit premature cardiac arrhythmias and stiffening of the arterial wall, and cardiac failure appears to be the main cause of death; yet these
tissues are not burdened with an abnormally - high burden of p16Ink4a -
senescent cells, and accordingly, ablation p16Ink4a - positive
senescent cells in these animals had little
tissue - specific or survivorship phenotypic impact.
These data indicate that cellular senescence is causally implicated
in generating age - related phenotypes and that removal of
senescent cells can prevent or delay
tissue dysfunction and extend healthspan.
Only
in the last 10 years, with increasing knowledge of the
senescent phenotype and the ability to detect
senescent cells in human
tissues, have biologists been able to investigate the relationship between cellular senescence and disease.
An enzyme called SETD8 appears to play a critical role
in cellular senescence onset
Senescent cells may have stopped dividing, but they continue to remain active — churning out a specific cocktail of factors that increases inflammation and breaks down
tissue among other things.